Experiment 346849
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | HANAUSKE,AR: CATIMEL,G: AAMDAL,S: TEN BOKKEL HUININK,W: PARIDAENS,R: PAVILIDIS,N: KAYE,SB: TE VELDE,A: WANDERS,J: VERWEIJ,J:. (1996). PHASE II CLINICAL TRIALS WITH RHIZOXIN IN BREAST AND MELANOMA.. 73(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | 19 BREAST CANCER AND 26 MELANOMA PATIENTS PARTICIPATED IN A PHASE II CLINICAL TRIAL. RHIZOXIN CAN BE SAFELY ADMINISTERED AT 2 MG/M-2 EVERY 3 WEEKS, HOWEVER IT HAS LITTLE ACTIVITY IN PATIENTS WITH ADVANCED BREAST CANCER AND MELANOMA. |
| Dose amount | 2.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |